Promising Predictors of preeclampsia  Creatinine Kinase and Tyrosine Kinase 1 in preeclamptic pregnant women in the third trimester of pregnancy

Edebiri O.E; Nwankwo A.A; Akpe P. E; Mbanaso E.I; Onwuka K. C; Ohiwerei W.O; Omende K

doi:10.62951/ijhsb.v2i2.366

Authors

Edebiri O.E Universitas Ambrose Alli, Ekpoma
Nwankwo A.A Universitas Negeri Abia
Akpe P. E Universitas Benin
Mbanaso E.I Universitas Negeri Abia
Onwuka K. C Universitas Negeri Imo
Ohiwerei W.O Pusat Diagnostik dan Pelatihan Penelitian Global Ohilux
Omende K Universitas Negeri Imo

DOI:

https://doi.org/10.62951/ijhsb.v2i2.366

Keywords:

Cardiac markers, Creatinine Kinase (CK), Preeclampsia, Tyrosine Kinase 1 (TK1)

Abstract

The potential of cardiac markers in predicting preeclampsia, such as Creatinine Kinase (CK) and Tyrosine Kinase 1 (TK1), has emerged as promising due to their involvement in the pathophysiology of this pregnancy complication. Preeclampsia is characterized by hypertension and organ dysfunction, and it can lead to significant maternal and fetal morbidity if not detected early. Early identification of preeclampsia is critical for preventing severe complications, and biomarkers like CK and TK1 can provide valuable insights. This study aimed to investigate the role of CK and TK1 as potential predictors of preeclampsia in the third trimester of pregnancy. Forty (40) consenting pregnant women were recruited from St. Philomina Catholic Hospital, Edo State, Nigeria. Participants were divided into two groups: twenty (20) normotensive pregnant women and twenty (20) preeclamptic pregnant women in their third trimester. Blood samples were collected and processed using a bucket centrifuge at 2500 RPM for 10 minutes, and plasma was stored frozen for further analysis. Tyrosine Kinase 1 was analyzed by fluorescence immunoassay, and Creatinine Kinase was measured using a spectrophotometric method. Data obtained were analyzed using GraphPad Prism 9, with results expressed as mean ± SEM. Statistical significance was set at a P-value of ≤ 0.05. The study found a statistically significant increase in the levels of both CK and TK1 in preeclamptic women compared to normotensive controls. These findings suggest that CK and TK1 could serve as predictive biomarkers for identifying and monitoring preeclampsia, aiding in early diagnosis and timely interventions

Downloads

Download data is not yet available.

References

Al-Hadi, H. A., & Fox, K. A. (2009). Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos University Medical Journal, 9(3), 231.

Ali, Z., Khaliq, S., Zaki, S., Ahmad, H. U., & Lone, K. P. (2019). Altered expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, and Soluble Fms-like Tyrosine Kinase-1 in peripheral blood mononuclear cells from normal and preeclamptic pregnancies. Journal of Physiology Investigation, 62(3), 117-122.

Aljameel, S. S., Alzahrani, M., Almusharraf, R., Altukhais, M., Alshaia, S., Sahlouli, H., ... & Alsumayt, A. (2023). Prediction of preeclampsia using machine learning and deep learning models: A review. Big Data and Cognitive Computing, 7(1), 32.

Armaly, Z., Jadaon, J. E., Jabbour, A., & Abassi, Z. A. (2018). Preeclampsia: Novel mechanisms and potential therapeutic approaches. Frontiers in Physiology, 9, 973.

Asmanidar, A., & Emilda, E. (2024). Optimizing maternal healthcare: Holistic strategies for early detection and management of preeclampsia. Science Midwifery, 12(1), 158-167.

Baselga, J. (2006). Targeting tyrosine kinases in cancer: The second wave. Science, 312(5777), 1175-1178.

Beáta, C. (2022). Investigating novel and conventional blood biomarkers for diagnosis and prognosis of cardiovascular disorders.

Bodor, G. S. (2016). Biochemical markers of myocardial damage. Ejifcc, 27(2), 95.

Chen, M. H., Kerkelä, R., & Force, T. (2008). Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation, 118(1), 84-95.

Duley, L. (2009, June). The global impact of pre-eclampsia and eclampsia. In Seminars in Perinatology, 33(3), 130-137. WB Saunders.

Hasan, S., Mahmud, Z., Hossain, M., & Islam, S. (2024). Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: A prospect towards the targeted therapy. Molecular Biology Reports, 51(1), 1-25.

Herraiz, I., Llurba, E., Verlohren, S., Galindo, A., & Spanish Group for the Study of Angiogenic Markers in Preeclampsia. (2018). Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies. Fetal Diagnosis and Therapy, 43(2), 81-89.

Horjus, D. L., Bokslag, A., Hooijberg, F., Hutten, B. A., Middeldorp, S., & de Groot, C. J. (2019). Creatine kinase and blood pressure in women with a history of early-onset preeclampsia. Pregnancy Hypertension, 15, 118-122.

Kashani, K., Rosner, M. H., & Ostermann, M. (2020). Creatinine: From physiology to clinical application. European Journal of Internal Medicine, 72, 9-14.

MacDonald, T. M., Walker, S. P., Hannan, N. J., Tong, S., & Tu'uhevaha, J. (2022). Clinical tools and biomarkers to predict preeclampsia. EBioMedicine, 75.

Maguire, C., Ueland, P. M., Tell, G. S., Seghieri, G., Ness, R. B., & Saugstad, O. D. (2015). Maternal circulating cortisol and risk of preeclampsia: Evidence for an interaction with stress-related disorders. Hypertension Pregnancy, 34(3), 320-328.

Marrufo-Gallegos, K. C., Villafán-Bernal, J. R., Espino-y-Sosa, S., Estrada-Gutierrez, G., Guzmán-Guzmán, I. P., Martinez-Portilla, R. J., & Torres-Torres, J. (2023). Influential serum kinases (Non-sFlt-1) and phosphatases in preeclampsia—Systematic review and meta-analysis. International Journal of Molecular Sciences, 24(16), 12842.

Pant, V., Yadav, B. K., & Sharma, J. (2019). A cross-sectional study to assess the sFlt-1: PlGF ratio in pregnant women with and without preeclampsia. BMC Pregnancy and Childbirth, 19, 1-8.

Rashid, S., Malik, A., Khurshid, R., Faryal, U., & Qazi, S. (2019). The diagnostic value of biochemical cardiac markers in acute myocardial infarction. Myocardial Infarction, 23.

Saenger, A. K. (2010). A tale of two biomarkers: The use of troponin and CK-MB in contemporary practice. Clinical Laboratory Science, 23(3), 134.

Tejomani, M. (2013). A study of creatine kinase activity, serum creatinine and creatinine clearance in hypothyroidism (Doctoral dissertation, Rajiv Gandhi University of Health Sciences, India).